Biodiversity and land use
Bristol Myers Squibb is committed to the conservation of biodiversity. Guided by our 2010 Goals our facilities adopted endangered or threatened species that are locally significant.
Both exotic and common plants have an important role to play in our mission to help patients prevail over serious diseases. Here is a list of our facilities and the animal and plant species they are protecting, with the help of government and private organizations.
|Facility Location||Endangered Species|
|Aichi, Japan||Loggerhead Turtle
|Cruiserath, Ireland||Marsh Fritillary Butterfly|
|Devens, Massachusetts||Blanding Turtle|
|Humacao, Puerto Rico||Humacao Wildlife Reserve (various)|
|Princeton, New Jersey||Cooper's Hawk (Accipiter cooperii)|
|Moreton, England||Natterjack Toad|
|New Brunswick, New Jersey||Yellow Giant Hyssop (Agastache eptoides)|
|New York City, New York||Peregrine Falcon|
|Syracuse, New York||Chittenango Ovate Amber Snail|
The Sustainability 2010 Goals also addressed land preservation. We’re committed to significantly reducing our global property footprint. Through our partnership with government agencies and other organizations, Bristol Myers Squibb has supported conservation of 1,616 hectares of biologically diverse habitat in Australia, Brazil, Indonesia, Ireland, Mexico, China, Canada and the United States. Exceeding our 2010 Goal.
In addition, our facilities in Lawrenceville, New Jersey; and Wallingford, Connecticut earned Wildlife Habitat Council certification for various wildlife habitat projects.